AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmer, L.
Right arrow Articles by Chalon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmer, L.
Right arrow Articles by Chalon, S.
Agricola
Right arrow Articles by Zimmer, L.
Right arrow Articles by Chalon, S.
American Journal of Clinical Nutrition, Vol. 75, No. 4, 662-667, April 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids1,2,3

Luc Zimmer, Sylvie Vancassel, Sylvain Cantagrel, Patrick Breton, Séraphin Delamanche, Denis Guilloteau, Georges Durand and Sylvie Chalon

1 From INSERM U316, Laboratoire de Biophysique Médicale et Pharmaceutique, Université François Rabelais, Tours, France (LZ, SC, DG, and SC); the INRA, Laboratoire de Nutrition et Sécurité Alimentaire, Jouy-en-Josas, France (SV and GD); and the Centre d'Etudes du Bouchet, Vert-le-Petit, France (PB and SD).

Background: Several findings in humans support the hypothesis of links between n-3 polyunsaturated fatty acid (PUFA) status and psychiatric diseases.

Objective: The involvement of PUFAs in central nervous system function can be assessed with the use of dietary manipulation in animal models. We studied the effects of chronic dietary n-3 PUFA deficiency on mesocorticolimbic dopamine neurotransmission in rats.

Design: Using dual-probe microdialysis, we analyzed dopamine release under amphetamine stimulation simultaneously in the frontal cortex and the nucleus accumbens. The messenger RNA (mRNA) expression of vesicular monoamine transporter2 and dopamine D2 receptor was studied with the use of in situ hybridization. The protein expression of the synthesis-limiting enzyme tyrosine 3-monooxygenase (tyrosine 3-hydroxylase) was studied with the use of immunocytochemistry.

Results: Dopamine release was significantly lower in both cerebral areas in n-3 PUFA–deficient rats than in control rats, but this effect was abolished in the frontal cortex and reversed in the nucleus accumbens by reserpine pretreatment, which depletes the dopamine vesicular storage pool. The mRNA expression of vesicular monoamine transporter2 was lower in both cerebral areas in n-3 PUFA–deficient rats than in control rats, whereas the mRNA expression of D2 receptor was lower in the frontal cortex and higher in the nucleus accumbens in n-3 PUFA–deficient rats than in control rats. Finally, tyrosine 3-monooxygenase immunoreactivity was higher in the ventral tegmental area in n-3 PUFA–deficient rats than in control rats.

Conclusions: Our results suggest that the mesolimbic dopamine pathway is more active whereas the mesocortical pathway is less active in n-3 PUFA–deficient rats than in control rats. This provides new neurochemical evidence supporting the effects of n-3 PUFA deficiency on behavior.

Key Words: Dopamine • mesocorticolimbic pathway • frontal cortex • microdialysis • n-3 polyunsaturated fatty acids • nucleus accumbens • rats




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
S. E Carlson
Early determinants of development: a lipid perspective
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1523S - 1529S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. E Carlson
Docosahexaenoic acid supplementation in pregnancy and lactation
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 678S - 684S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Song, M. S. Manku, and D. F. Horrobin
Long-Chain Polyunsaturated Fatty Acids Modulate Interleukin-1{beta}-Induced Changes in Behavior, Monoaminergic Neurotransmitters, and Brain Inflammation in Rats
J. Nutr., May 1, 2008; 138(5): 954 - 963.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Vancassel, S. Leman, L. Hanonick, S. Denis, J. Roger, M. Nollet, S. Bodard, I. Kousignian, C. Belzung, and S. Chalon
n-3 Polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice
J. Lipid Res., February 1, 2008; 49(2): 340 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. L. Pongrac, P. J. Slack, and S. M. Innis
Dietary Polyunsaturated Fat that Is Low in (n-3) and High in (n-6) Fatty Acids Alters the SNARE Protein Complex and Nitrosylation in Rat Hippocampus
J. Nutr., August 1, 2007; 137(8): 1852 - 1856.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Coti Bertrand, J. R. O'Kusky, and S. M. Innis
Maternal Dietary (n-3) Fatty Acid Deficiency Alters Neurogenesis in the Embryonic Rat Brain
J. Nutr., June 1, 2006; 136(6): 1570 - 1575.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. C. DeMar Jr., K. Ma, J. M. Bell, M. Igarashi, D. Greenstein, and S. I. Rapoport
One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats
J. Lipid Res., January 1, 2006; 47(1): 172 - 180.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Pifferi, F. Roux, B. Langelier, J.-M. Alessandri, S. Vancassel, M. Jouin, M. Lavialle, and P. Guesnet
(n-3) Polyunsaturated Fatty Acid Deficiency Reduces the Expression of Both Isoforms of the Brain Glucose Transporter GLUT1 in Rats
J. Nutr., September 1, 2005; 135(9): 2241 - 2246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. C McCann and B. N Ames
Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals
Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K.-F. Ng and S. M. Innis
Behavioral Responses Are Altered in Piglets with Decreased Frontal Cortex Docosahexaenoic Acid
J. Nutr., October 1, 2003; 133(10): 3222 - 3227.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Aid, S. Vancassel, C. Poumes-Ballihaut, S. Chalon, P. Guesnet, and M. Lavialle
Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus
J. Lipid Res., August 1, 2003; 44(8): 1545 - 1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition